High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial

Published:2022-12-20 Issue:5 Volume:68 Page:2123-2139
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Keating Shelley E.^ORCID,Croci Ilaria,Wallen Matthew P.,Cox Emily R.,Thuzar Moe,Pham Uyen,Mielke Gregore I.,Coombes Jeff S.,Macdonald Graeme A.,Hickman Ingrid J.

Funder

Diabetes Australia Research Program

Exercise and Sports Science Australia

National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-022-07779-z.pdf

Reference55 articles.

1. Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32–42.

2. Younossi ZM, Golabi P, de Avila L et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71:793–801.

3. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.

4. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016;64(6):1388–1402.

5. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52:79–104.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Intensity Interval Training Decreases Circulating HMGB1 in Individuals with Insulin Resistance; Plasma Lipidomics Identifies Associated Cardiometabolic Benefits;2024-08-21

2. Exercise improves surrogate measures of liver histological response in metabolic dysfunction‐associated steatotic liver disease;Liver International;2024-06-07

3. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice;Metabolism;2024-06

4. Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH;Journal of Hepatology;2024-06

5. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective;Hepatology International;2024-05-08